FDA has accepted BLA for BAT2506, a biosimilar of Simponi (golimumab) for all approved doses, formulations, & indications of reference product, with a request for interchangeability (BsUFA: May 16, 2026) https://t.co/kVFAz9ltlr https://t.co/LqdzsXlqER
Links:
Bio-Thera Reports the US FDA’s BLA Acceptance of BAT2506 (Biosimilar, Simponi) …
https://buff.ly/ViP5Ctv
Jul-23-2025
